APUA-Alliance pour l’usage prudent des antibiotiques
http://www.antibiotic.org (voir aussi Le Point No. 24 page 20)

AR InfoBank-Banque de données de l’OMS sur la résistance aux antimicrobiens
http://oms2.b3e.jussieu.fr/arinfobank

BUBL Catalogue des ressources Internet - Maladies infectieuses
http://bubl.ac.uk/link/i/infectiousdiseases.htm

Center for Adaptation Genetics and Drug Resistance
http://www.healthsci.tufts.edu/labs/Sblevy/home.html

Center for Complex Infections Diseases
http://www.ccid.org/

Centers for Disease Control. Page d’accueil sur la résistance aux antimicrobiens
http://www.cdc.gov/drugresistance/

CIA. The global infectious disease threat and its implications for the United States (La menace mondiale des maladies infectieuses et ses implications aux Etats Unis). 1999
http://www.odci.gov/cia/publications/nie/report/nie99-17d.html

EARSS-European antimicrobial resistance surveillance System (Système européen de surveillance de la résistance aux antimicrobiens)
http://EARSS.rivm.nl

Eurosurveillance
http://eurosurv.org/

Initiative mondiale pour l’éradication de la poliomyélite
http://www.polioeradication.org

Infectious Disease News
http://www.slackinc.com/general/idn/idnhome.htm

International Society for Infectious Diseases
http://isid.organize-it.com/

Université Johns Hopkins - Maladies infectieuses
http://www.hopkins-id.edu/indexidlinks.html

Institut Karolinska, Suède
http://micf.mic.ki.se/Diseases/

National Foundation for Infectious Diseases
http://www.nfid.org/

Projet Icare: Intensive Care Antimicrobial Resistance Epidemiology
http://www.sph.emory.edu/ICARE/

Faire reculer le paludisme
http://www.rbm.who.int/

Halte à la tuberculose
http://www.stoptb.org

The Hot Zone: Emerging Infectious Diseases Reports and Web Sites
http://www.qis.net/~edwardmc/eid.htm

UK Public Health Laboratory
http://www.phls.co.uk/

US National Center for Infectious Diseases
http://www.cdc.gov/ncidod/eidtopics.htm

Washington University Infectious Disease Division, USA
http://www.id.wustl.edu/

OMS Maladies transmissibles Page d’accueil
http://www.who.int/health-topics/idindex.htm

WHO/TDR (Programme spécial de recherche et de formation concernant les maladies tropicales)
http://www.who.int/tdr

Bibliographies sélectionnées:

Coast J, Smith RD, Millar MR. An economic perspective on policy to reduce antimicrobial resistance. Soc Sci Med 1998;46:29-38.

Fidler DP. Legal issues associated with antimicrobial drug resistance. Emerg Infect Dis 1998;4:169-77.

Finch RG, Williams RJ. Eds. Antibiotic resistance. Clin Infect Dis 1999;5(2).

Goldmann DA, Huskins WC. Control of nosocomial antimicrobial-resistant bacteria: a strategic priority for hospitals worldwide. Clin Infect Dis 1997;24 (Supplément l):S139-45.

Hart CA, Kariuki S. Antimicrobial resistance in developing countries. BMJ 1998;317:647-650.

Institute of Medicine. Antimicrobial resistance: issues and options. Workshop report. Washington D.C.: National Academy Press; 1998. http://books.nap.edu/books/0309060842/html/R1.html#pagetop

Pittet D et al. Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Lancet 2000;356: 1307-1312.

Polk HC Jr, Christmas AB. Prophylactic antibiotics in surgery and surgical wound infections. Am Surg 2000;66:105-11.

UK Standing Medical Advisory Committee Sub-Group on Antimicrobial Resistance. The path of least resistance. London: Department of Health; 1998. http://www.open.gov.uk/doh/smac.htm

OMS. Assemblée mondiale de la santé 1998. Maladies émergentes et autres maladies transmissibles: résistance aux antimicrobiens. WHA51.17, Point 21.3 de l’ordre du jour. http://www.who.int/emc/

WHO. Anti-tuberculosis drug resistance in the world. The WHO/International Union Against Tuberculosis and Lung Disease global report on anti-tuberculosis drug resistance surveillance 1994-97. Geneva: World Health Organization; 1997. WHO/TB/97.229.

OMS. Principes pour la prise en charge de la tuberculose à bacilles résistants. Genève: Organisation mondiale de la santé; 1997. WHO/TB/96.210.

WHO. Integrated management of childhood illnesses: A WHO/UNICEF initiative. WHO Bulletin 1997;75 (Supplement 1).

WHO. The medical impact of the use of antimicrobials in food animals: Report and proceedings of a WHO meeting, Berlin, Germany, 13-17 October 1997. Geneva: World Health Organization; 1997. WHO/EMC/ZOO/97.4.

OMS. Le traitement de la tuberculose. Deuxième édition. Principes à l’intention des programmes nationaux. Genève: Organisation mondiale de la santé; 1997. WHO/TB/97.220.

WHO. Use of quinolones in food animals and potential impact on human health. Report and proceedings of a WHO meeting, Geneva, Switzerland, 2-5 June 1998. Geneva: World Health Organization; 1998. WHO/EMC/ZDI/98.12.

WHO. Basis for the development of an evidence-based case-management strategy for MDR-TB within the WHO’s DOTS Strategy. Geneva: World Health Organization; 1999. WHO/TB/99.269.

WHO. Containing antimicrobial resistance. Review of the literature and report of a WHO workshop on the development of a global strategy for the containment of antimicrobial resistance. Geneva, Switzerland, 4-5 February 1999. Geneva: World Health Organization; 1999. WHO/CDS/CSR/DRS/99.2. www.who.int/emc/WHO_docs/general.htm

WHO. WHO report on infectious diseases. Removing obstacles to healthy development. Geneva: World Health Organization; 1999. WHO/CDS/99.1. http://www.who.int/infectious-disease-report/

WHO. Anti-tuberculosis drug resistance in the world. Report no. 2. Prevalence and trends. The WHO/International Union Against Tuberculosis and Lung Disease global report on antiruberculosis drug resistance surveillance. Geneva: World Health Organization; 2000. WHO/CDS/TB/2000.278.

WHO. Global tuberculosis control: WHO Report 2000. Geneva: World Health Organization; 2000. WHO/CDS/TB/2000.275.

WHO. Guidelines for establishing DOTS-Plus pilot projects for the management of multidrug-resistant tuberculosis (MDR-TB). Geneva: World Health Organization; 2000. WHO/CDS/TB/2000.279.

OMS. Prise en charge de l’enfant atteint d’infection grave ou de malnutrition sévère: Directives pour les soins au premier niveau de recours dans les pays en développement. Genève: Organisation mondiale de la santé; 2000. WHO/FCH/00.1.

WHO. World Health Organization report on infectious diseases 2000. Overcoming antimicrobial résistance. Geneva: World Health Organization; 2000. WHO/CDS/2000.2. http://www.who.int/infectious-disease-report-2000

WHO. Surveillance standards for antimicrobial resistance. Geneva: World Health Organization; 2000. CDS/CSR/DRS 2000.2 (in preparation).